BSE filing, NSE: NEXUSCOMMO. Summary written from the filing by ALFA Finder's alert engine.
Nexus Surgical and Medicare Ltd: key numbers
- Share price
- ₹21.48
- Market cap
- ₹11.75 Cr
- Revenue (annual)
- ₹7.87 Cr
- Net profit (annual)
- ₹0.74 Cr
- P/E (TTM)
- 14.9×Sector 43.1×
- Promoter holding
- 18.73%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nexus Surgical and Medicare Ltd
All →Nexus Surgical and Medicare Other Announcement
Nexus Surgical and Medicare Limited filed its quarterly Regulation 74(5) certificate from its RTA, confirming dematerialization activities for the period ended 30th September, 2026.
Nexus Surgical and Medicare Management Change
Shareholders approved the appointment of Mr. Anish More as Managing Director of Nexus Surgical and Medicare for a three-year term, effective September 2, 2026.
- Execution
- 3 years
Nexus Surgical and Medicare Annual General Meeting
Nexus Surgical And Medicare Limited held its 35th Annual General Meeting on September 25, 2026. Shareholders discussed and voted on routine agenda items.
Nexus Surgical and Medicare Price Movement Clarification
Nexus Surgical and Medicare Ltd clarified that recent stock price movements are purely market-driven, confirming no undisclosed information or pending corporate actions exist.
Nexus Surgical and Medicare Annual Report
Nexus Surgical and Medicare Limited filed its Annual Report and AGM Notice for the financial year 2025-26. The document details company performance and upcoming director appointments.
Nexus Surgical and Medicare Annual General Meeting
Nexus Surgical and Medicare Limited has scheduled its 35th Annual General Meeting for September 25, 2026, via video conferencing. The register of members will close accordingly.
Other board meeting date announcements
All →RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.